AI assistant
IMMUCELL CORP /DE/ — Director's Dealing 2017
Jul 28, 2017
34519_dirs_2017-07-28_f83dcf7a-af5c-41c0-8f35-0186babccf08.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2017-07-27
Reporting Person: PESSIN NORMAN H (See Explanation of Responses)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-07-27 | Common Stock | P | 170000 | $5.25 | Acquired | 170000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 480000 | Direct |
Footnotes
F1: The Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of common stock. The Reporting Person disclaims beneficial ownership of the shares of common stock reported herein except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Person is the beneficial owner of such shares of common stock for purposes of Section 16 or for any other purpose.
F2: Shares beneficially owned by the Reporting Person's spouse. The Reporting Person expressly disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.